Payment overview · 2025
General Payments
$41.54
2 reported records · 2 companies
Healthcare provider profile · identity verified
David Albert Williams, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · MEADVILLE, PA · NPI 1154372662
Verified facts
What the public records show
CMS Open Payments records show David Albert Williams, D.O. received $41.54 in general payments during 2025 across 2 reported records.
Lundbeck LLC accounted for 92.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lundbeck LLC | Unresolved — no canonical attribution shown | $38.54 | 92.8% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $3.00 | 7.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $38.54 | 1 |
| Food and Beverage | $3.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $38.54 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $3.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 20 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 2299 | 175 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1088 | 80 |
| Potassium Chloride | Potassium Chloride | 1061 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 959 | 69 |
| Duloxetine Hcl | Duloxetine Hcl | 914 | 76 |
| Citalopram Hbr | Citalopram Hydrobromide | 891 | 44 |
| Atorvastatin Calcium | Atorvastatin Calcium | 872 | 154 |
| Eliquis | Apixaban | 850 | 79 |
| Bumetanide | Bumetanide | 808 | 40 |
| Omeprazole | Omeprazole | 804 | 98 |
| Pantoprazole Sodium | Pantoprazole Sodium | 781 | 97 |
| Metoprolol Succinate | Metoprolol Succinate | 760 | 103 |
| Gabapentin | Gabapentin | 745 | 59 |
| Amlodipine Besylate | Amlodipine Besylate | 702 | 103 |
| Furosemide | Furosemide | 652 | 68 |
| Donepezil Hcl | Donepezil Hcl | 649 | 42 |
| Losartan Potassium | Losartan Potassium | 619 | 68 |
| Lisinopril | Lisinopril | 611 | 125 |
| Mirtazapine | Mirtazapine | 594 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 572 | 80 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 529 | 21 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 528 | 81 |
| Sertraline Hcl | Sertraline Hcl | 460 | 56 |
| Montelukast Sodium | Montelukast Sodium | 442 | 52 |
| Famotidine | Famotidine | 435 | 30 |
| Risperidone | Risperidone | 387 | 17 |
| Olanzapine | Olanzapine | 384 | 12 |
| Memantine Hcl | Memantine Hcl | 382 | 20 |
| Simvastatin | Simvastatin | 370 | 60 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 339 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 326 | 67 |
| Allopurinol | Allopurinol | 324 | 40 |
| Metformin Hcl | Metformin Hcl | 321 | 60 |
| Valsartan | Valsartan | 317 | 53 |
| Spironolactone | Spironolactone | 244 | 37 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 243 | suppressed |
| Sucralfate | Sucralfate | 237 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 233 | 30 |
| Trazodone Hcl | Trazodone Hcl | 231 | 14 |
| Tradjenta | Linagliptin | 217 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 199 | 15 |
| Lorazepam | Lorazepam | 194 | 46 |
| Prednisone | Prednisone | 192 | 101 |
| Carvedilol | Carvedilol | 186 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 180 | 27 |
| Pioglitazone Hcl | Pioglitazone Hcl | 177 | 31 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 176 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 173 | 34 |
| Aripiprazole | Aripiprazole | 171 | suppressed |
| Irbesartan | Irbesartan | 165 | 32 |
| Tramadol Hcl | Tramadol Hcl | 164 | 36 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 159 | 13 |
| Levetiracetam | Levetiracetam | 149 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 148 | suppressed |
| Finasteride | Finasteride | 144 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 129 | suppressed |
| Atenolol | Atenolol | 127 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 127 | 18 |
| Cephalexin | Cephalexin | 124 | 59 |
| Xarelto | Rivaroxaban | 124 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 121 | 11 |
| Bupropion Xl | Bupropion Hcl | 120 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 120 | 24 |
| Clonazepam | Clonazepam | 117 | 13 |
| Labetalol Hcl | Labetalol Hcl | 113 | 21 |
| Primidone | Primidone | 112 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 110 | 83 |
| Januvia | Sitagliptin Phosphate | 107 | 13 |
| Diltiazem 24hr Er | Diltiazem Hcl | 104 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 101 | suppressed |
| Loperamide | Loperamide Hcl | 101 | 17 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 100 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 98 | 19 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 96 | 48 |
| Fenofibrate | Fenofibrate Nanocrystallized | 89 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 89 | 17 |
| Jardiance | Empagliflozin | 87 | 17 |
| Glipizide Er | Glipizide | 83 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 83 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 83 | 17 |
| Glipizide | Glipizide | 82 | 13 |
| Buspirone Hcl | Buspirone Hcl | 81 | 12 |
| Baclofen | Baclofen | 80 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 80 | 19 |
| Synthroid | Levothyroxine Sodium | 80 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 75 | 32 |
| Chlorthalidone | Chlorthalidone | 75 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 75 | 24 |
| Trintellix | Vortioxetine Hydrobromide | 75 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 74 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 74 | 11 |
| Propranolol Hcl | Propranolol Hcl | 74 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 72 | 15 |
| Methocarbamol | Methocarbamol | 71 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 71 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 69 | suppressed |
| Mounjaro | Tirzepatide | 68 | suppressed |
| Ezetimibe | Ezetimibe | 67 | 17 |
| Verapamil Sr | Verapamil Hcl | 64 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 62 | suppressed |
| Nifedipine Er | Nifedipine | 61 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | suppressed |
| Fluconazole | Fluconazole | 60 | 26 |
| Latanoprost | Latanoprost | 60 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 58 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 58 | 13 |
| Alprazolam | Alprazolam | 57 | suppressed |
| Lansoprazole | Lansoprazole | 57 | suppressed |
| Meloxicam | Meloxicam | 57 | 21 |
| Entresto | Sacubitril/Valsartan | 56 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 55 | suppressed |
| Azithromycin | Azithromycin | 55 | 34 |
| Digoxin | Digoxin | 54 | suppressed |
| Ozempic | Semaglutide | 54 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 22 |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 53 | suppressed |
| Olanzapine Odt | Olanzapine | 52 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 52 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 52 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 51 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 49 | 32 |
| Glimepiride | Glimepiride | 49 | suppressed |
| Methadone Hcl | Methadone Hcl | 49 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 49 | suppressed |
| Paliperidone Er | Paliperidone | 49 | suppressed |
| Torsemide | Torsemide | 49 | suppressed |
| Methotrexate | Methotrexate Sodium | 48 | suppressed |
| Ondansetron Odt | Ondansetron | 48 | 29 |
| Levofloxacin | Levofloxacin | 47 | 26 |
| Myrbetriq | Mirabegron | 47 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 47 | 33 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 47 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 46 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 45 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 45 | 27 |
| Divalproex Sodium Er | Divalproex Sodium | 44 | suppressed |
| Mupirocin | Mupirocin | 43 | 31 |
| Sumatriptan Succinate | Sumatriptan Succinate | 42 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 41 | suppressed |
| Ibuprofen | Ibuprofen | 39 | 13 |
| Testosterone | Testosterone | 39 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 38 | 11 |
| Trulicity | Dulaglutide | 38 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 36 | suppressed |
| Fentanyl | Fentanyl | 36 | suppressed |
| Brilinta | Ticagrelor | 35 | suppressed |
| Nystatin | Nystatin | 35 | 25 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 34 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 33 | suppressed |
| Ramipril | Ramipril | 33 | suppressed |
| Colchicine | Colchicine | 31 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 30 | 12 |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 30 | suppressed |
| Calcitriol | Calcitriol | 29 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 29 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 28 | 13 |
| Carbamazepine | Carbamazepine | 27 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 27 | suppressed |
| Cimetidine | Cimetidine | 27 | suppressed |
| Ranolazine Er | Ranolazine | 27 | suppressed |
| Verapamil Er | Verapamil Hcl | 27 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 26 | 26 |
| Humalog | Insulin Lispro | 26 | suppressed |
| Lactulose | Lactulose | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 25 | 20 |
| Pregabalin | Pregabalin | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Gemtesa | Vibegron | 24 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 24 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 23 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 13 |
| Amoxicillin | Amoxicillin | 22 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 22 | 19 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 22 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 22 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 22 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 21 | 11 |
| Lidocaine Hcl | Lidocaine Hcl | 21 | 13 |
| Methimazole | Methimazole | 21 | suppressed |
| Lumigan | Bimatoprost | 20 | suppressed |
| Rexulti | Brexpiprazole | 20 | suppressed |
| Leflunomide | Leflunomide | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 18 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 18 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Hydroxyurea | Hydroxyurea | 17 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 17 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | suppressed |
| Erythromycin | Erythromycin Base | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Jantoven | Warfarin Sodium | 16 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Nystop | Nystatin | 15 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Acetic Acid | Acetic Acid | 13 | suppressed |
| Rivastigmine | Rivastigmine | 13 | suppressed |
| Telmisartan | Telmisartan | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 12 | 12 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 12 | suppressed |
| Teriparatide | Teriparatide | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Prasugrel Hcl | Prasugrel Hcl | 11 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $41.54 · 2 records | Lundbeck LLC | REXULTI, VOQUEZNA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lundbeck LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error